Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Treat Rev. 2009 Apr;35(2):160-6. doi: 10.1016/j.ctrv.2008.10.001. Epub 2008 Nov 13.

Adjuvant therapy for colon cancer: present and perspectives.

Author information

  • 1Medical Oncology, Oncology Institute of Southern Switzerland, 6500 Bellinzona, Switzerland.

Abstract

Colon cancer is the second cause of death for cancer worldwide. In most cases it is diagnosed when it is still localized to the intestinal wall or in regional lymphnodes. Post-operative systemic therapy with 5-fluorouracil and folinic acid in combination with Oxaliplatin is the standard option for patients with radically resected stage III disease. In stage II, the value of a post-operative treatment remains controversial, but the identification of prognostic factors, histopathological and molecular, may allow the selection of patients who can benefit from adjuvant treatment. The inclusion of molecular targeted agents in combination regimens with cytotoxics, already proven effective in advanced disease, is the main field of development in the most recent protocols of adjuvant therapy.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk